Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
about
Immunotherapy for tuberculosis: future prospectsTB vaccine development and the End TB Strategy: importance and current status.Hepatitis C Virus Inhibits Cell Surface Expression of HLA-DR, Prevents Dendritic Cell Maturation, and Induces Interleukin-10 ProductionAntibodies and tuberculosisRevaccination with Live Attenuated Vaccines Confer Additional Beneficial Nonspecific Effects on Overall Survival: A ReviewThe co-operonic PE25/PPE41 protein complex of Mycobacterium tuberculosis elicits increased humoral and cell mediated immune response.Modulation of Mycobacterium tuberculosis-specific humoral immune responses is associated with Strongyloides stercoralis co-infectionHistopathological Study of the Lungs of Mice Receiving Human Secretory IgA and Challenged with Mycobacterium tuberculosisCD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responsesAntibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting.The role of B cells and humoral immunity in Mycobacterium tuberculosis infectionTranscriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.B cells and antibodies in the defense against Mycobacterium tuberculosis infectionPreparation of monoclonal antibodies against mannosylated lipoarabinomannan (ManLAM), a surface antigen of BCG vaccine produced in Iran.A novel assay of antimycobacterial activity and phagocytosis by human neutrophils.Mycobacterium tuberculosis Zinc Metalloprotease-1 Elicits Tuberculosis-Specific Humoral Immune Response Independent of Mycobacterial Load in Pulmonary and Extra-Pulmonary Tuberculosis Patients.Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques.Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.Antibody-mediated immunity against tuberculosis: implications for vaccine developmentBrief Report: HIV-1 Infection Impairs CD16 and CD35 Mediated Opsonophagocytosis of Mycobacterium tuberculosis by Human Neutrophils.IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.A novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.The protective role of antibody responses during Mycobacterium tuberculosis infection.M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens.Successful TB treatment induces B-cells expressing FASL and IL5RA mRNA.The pathology of Mycobacterium tuberculosis infection.A Functional Role for Antibodies in Tuberculosis."The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturationActivated B cells in the granulomas of nonhuman primates infected with Mycobacterium tuberculosis.Oral immunogenicity of potato-derived antigens to Mycobacterium tuberculosis in mice.Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.Host-Directed Therapeutic Strategies for Tuberculosis.Malnutrition: Modulator of Immune Responses in Tuberculosis.Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.
P2860
Q26741261-7229C047-7E04-4361-BCA4-A07F7915CED9Q26748621-E1E54866-4C51-4A54-B04E-099F6217CD42Q27485530-E8E9785C-F30E-4428-B260-C5120A1D0CDAQ28067735-8B6ACFB6-B97B-47C7-8AED-D4EDFE1BCE25Q28596501-F573154D-6F6D-4B65-AD8F-BFCD8F08A028Q33381629-6395402A-49C3-47AC-856F-79B1217F00E5Q33664416-14683716-8039-4954-91A3-428C5C86EEFFQ34178105-5B6D4721-696C-47C0-8D71-286D5D81FA9BQ34309735-48AE6752-2AE7-49BC-BFA4-BD9C4308126CQ34377438-4FCC9D29-31E2-4ABC-B3DA-9FA40D2C3840Q35039807-DB8A61BC-C1BA-4D96-84B7-7F6E1A28C733Q35148364-9AD242E9-FB42-4AE0-BD6A-5B94D6B7FA2CQ35164284-93C46270-6352-4546-B7FE-63C510EEC12FQ35689518-6E07D36C-88E4-44D7-A736-C5038472A48BQ36237421-0E5A0975-9A29-47CF-A69E-6BAD3C67D735Q36238031-6558D010-475C-4CC3-AE65-710FA698D9DAQ36629051-F4F932E6-440B-4598-9631-75CA9FB525E4Q36715934-06B87667-8FE9-4A6D-896F-FC53F9B9AD16Q36747054-6133F9E5-24F1-4F2F-8FB4-9740EB878A8DQ36888486-FC61DE82-3D48-4017-9F71-30E3E820E708Q37033066-04B8A5BC-B296-4C2B-8412-605902198582Q37137882-025FA4AE-F186-474E-BF9F-74824921389CQ37246262-456EAEDF-A276-45ED-97CA-D517711D69EBQ37345928-69D8830F-4B29-48B2-9745-4E5039BCC2FAQ37356326-29387948-81C2-44B8-8073-8820A400362AQ37552026-70253B25-8B31-4042-A963-B74079C3F04CQ37609295-65106C20-CD5C-4F6A-979F-27A5FFEB60FEQ37678618-B23F8A59-5AD2-4E39-9DB4-53F1DF354B7AQ37683238-094D5B16-E62A-448C-BAF5-C0AD478ED1CBQ37709222-545C9EC9-CF58-4154-8826-1747B4D451AEQ37977379-2B76A73A-790B-45A6-9821-ADCAD2C74AEAQ39352413-48D7F708-20ED-499F-A49B-9A8EE7AA3DF7Q40213126-FE2F446A-78E1-4195-ACEE-F6E623761B4DQ40868823-6131F543-FF02-4EB7-9CBD-84FBB2BD97CCQ41879482-47B54DC6-DC91-4738-BF14-EE8E6B2AC68BQ43909012-5EC88DCC-64BA-417F-99EF-6835A83060D4Q44677966-54E57912-D2EE-4C99-90A1-7A4D2B836793Q45006012-1B83F051-9D51-41D1-8830-DBE9DD999128Q46180676-879ADEA4-415D-4F17-BA24-C0EB29769A5DQ49874317-B846A115-8424-4CF9-B790-7D0359826B84
P2860
Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
@en
type
label
Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
@en
prefLabel
Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
@en
P2093
P2860
P1476
Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies.
@en
P2093
A Blazevic
R M Heuertz
S de Vallière
P2860
P304
P356
10.1128/IAI.73.10.6711-6720.2005
P407
P577
2005-10-01T00:00:00Z